|
| |
| | | 65959 | | 03.02.2017 | | Takeda Pharma AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Ninlaro 2.3 mg | Hartkapseln | Capsules (Ixazomibum 2.3 mg) | L01XG03 | CI | | 02 | Ninlaro 3.0 mg | Hartkapseln | Capsules (Ixazomibum 3 mg) | L01XG03 | CI | | 03 | Ninlaro 4.0 mg | Hartkapseln | Capsules (Ixazomibum 4 mg) | L01XG03 | CI |
|
|
|
